Gujarat Alkalies & Chemicals Ltd
Gujarat Alkalies & Chemicals Ltd Q2 FY23 Results & Presentation Highlights: Revenue, Margins & Order Book
Q2 FY23 investor presentation: what the company reported on revenue, margins and projects.
Based on Gujarat Alkalies & Chemicals Ltd's Q2 FY23 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
For H1 FY 2022-23 (half year ending Sept 30, 2022), Net External Sales were Rs. EBITDA for H1 FY23 is Rs.
From Gujarat Alkalies & Chemicals Ltd's Q2 FY23 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- For H1 FY 2022-23 (half year ending Sept 30, 2022), Net External Sales were Rs. 2,214.27 crores (page 9).
- Profit After Tax (PAT) for H1 FY 2022-23 was Rs. 349.86 crores (page 9).
- Export sales for FY 2021-22 were Rs. 500 crores, up from Rs. 339 crores in FY 2020-21; for H1 FY 2022-23, exports were Rs. 342 crores (page 13).
- Installed production capacities detailed, e.g., Caustic Soda total capacity 585,750 MT (page 11).
2 more points management made on revenue & sales performance
Profitability & Margins
See what Gujarat Alkalies & Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- CS New Plant with Coal-based Power Plant (JV with NALCO):
- Capacity: 800 TPD + 130 MW
- Cost: Rs. 2300 Cr
- Status: CS Plant commissioned and stabilizing; Power Plant Unit #1 commissioned; Unit #2 expected Jan 2023
- Chloromethanes Plant at Dahej:
- Capacity: 300 TPD
- Cost: Rs. 850 Cr
- Status: Commissioned on 15 August 2022
- CH-17 Tank Farm:
- Cost: Rs. 80 Cr
- Status: Commissioned on 31 August 2022
- Hydrazine Hydrate Plant:
- Capacity: 30 TPD
- Cost: Rs. 405.5 Cr
- Status: Commissioned on 26 September 2022
- Caustic Soda Expansion at Dahej:
- Capacity: 525 TPD
- Cost: Rs. 550 Cr
- Status: Commissioned on 20 September 2022
- Phosphoric Acid (New Plant):
- Capacity: 100 TPD
- Cost: Rs. 520 Cr
- Status: 90.2% complete; commissioning expected by Feb 2023
- Coal-Based Power Plant at Dahej:
- Capacity: 65 MW
- Cost: Rs. 325 Cr
- Status: Project on hold
- Chlorotoluene Project at Dahej:
- Capacity: 90 TPD
- Cost: Rs. 350 Cr
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Gujarat Alkalies & Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Gujarat Alkalies & Chemicals Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.0K Cr, net loss ₹20 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Gujarat Alkalies & Chemicals Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- GOCL Corporation Ltd (Q2 FY23)
EBITDA Margin:** 42.56% . Key investor presentation takeaways from GOCL Corporation Ltd's Q2 FY23 investor presentation — and how it ranks against sector peers.
Frequently Asked Questions
What were Gujarat Alkalies & Chemicals Ltd Q2 FY23 results?
For H1 FY 2022-23 (half year ending Sept 30, 2022), Net External Sales were Rs. EBITDA for H1 FY23 is Rs.
What is Gujarat Alkalies & Chemicals Ltd share price analysis?
Gujarat Alkalies & Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 70.7 with a market cap of ₹4,691 Cr. Investors should review the full earnings analysis for detailed insights.
Is Gujarat Alkalies & Chemicals Ltd planning capital expenditure?
CS New Plant with Coal-based Power Plant (JV with NALCO): - Capacity: 800 TPD + 130 MW - Cost: Rs.
Keep Gujarat Alkalies & Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.